Published in Clin Vaccine Immunol on January 07, 2009
Multifunctional Analysis of CD4+ T-Cell Response as Immune-Based Model for Tuberculosis Detection. J Immunol Res (2015) 0.88
Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype. Cell Microbiol (2012) 0.88
Immune response to mycobacterial infection: lessons from flow cytometry. Clin Dev Immunol (2013) 0.79
Multi-functional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists. Clin Exp Immunol (2014) 0.77
Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening. Tuberculosis (Edinb) (2015) 0.76
Treatment of latent tuberculosis infection induces changes in multifunctional Mycobacterium tuberculosis-specific CD4(+) T cells. Med Microbiol Immunol (2015) 0.76
Immunology of tuberculosis. Annu Rev Immunol (2001) 14.26
Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis (2004) 8.41
Lymphocyte responses and cytokines. Cell (1994) 8.35
Specific immune-based diagnosis of tuberculosis. Lancet (2000) 6.81
Immunity to intracellular bacteria. Annu Rev Immunol (1993) 6.81
A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods (1983) 6.71
Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep (2005) 6.45
Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med (2004) 5.78
Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med (1995) 4.12
T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis (2007) 3.96
Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA (2001) 3.53
Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet (2001) 3.15
Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood (1995) 3.12
Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol (2000) 3.03
The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today (1994) 3.01
The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today (1994) 2.66
Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology (1994) 2.61
Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recomm Rep (2003) 2.28
Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis (2007) 2.21
Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods (1998) 2.10
Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis (2001) 2.02
Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol (2005) 2.02
Optimization of whole blood antigen-specific cytokine assays for CD4(+) T cells. Cytometry (2000) 1.83
Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection (2007) 1.79
Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol (1996) 1.60
Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis (2007) 1.48
Cytokine flow cytometry: understanding cytokine biology at the single-cell level. J Clin Immunol (1997) 1.36
Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry (1998) 1.35
Lymphocyte subpopulation reference ranges for monitoring human immunodeficiency virus-infected Chinese adults. Clin Diagn Lab Immunol (1996) 1.32
Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma. Emerg Infect Dis (2007) 1.25
Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays. Clin Infect Dis (2007) 1.24
Single cell analyses of cytokine production. Curr Opin Immunol (1997) 1.15
Simple and rational approach to the identification of Mycobacterium tuberculosis, Mycobacterium avium complex species, and other commonly isolated mycobacteria. J Clin Microbiol (2001) 1.11
Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry. Clin Exp Immunol (2005) 1.07
The detection and enumeration of cytokine-secreting cells in mice and man and the clinical application of these assays. J Immunol Methods (1989) 1.03
Confirmation of Mycobacterium tuberculosis infection by flow cytometry after ex vivo incubation of peripheral blood T cells with an ESAT-6-derived peptide pool. Cytometry B Clin Cytom (2004) 1.02
Induction of CD69 antigen on normal CD4+ and CD8+ lymphocyte subsets and its relationship with the phenotype of responding T-cells. Cytometry (1999) 0.92
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet (2009) 7.22
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis. Clin Infect Dis (2014) 2.75
T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med (2010) 2.36
Use of variable-number tandem-repeat typing to differentiate Mycobacterium tuberculosis Beijing family isolates from Hong Kong and comparison with IS6110 restriction fragment length polymorphism typing and spoligotyping. J Clin Microbiol (2005) 1.87
Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong. Chest (2003) 1.65
Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong. J Antimicrob Chemother (2005) 1.64
Antituberculosis drugs and hepatotoxicity. Respirology (2006) 1.62
Lack of association between presentation of diarrhoeal symptoms and faecal isolation of Aeromonas spp. amongst outpatients in Hong Kong. J Med Microbiol (2006) 1.52
Risk of active tuberculosis among schoolchildren in Hong Kong. Arch Pediatr Adolesc Med (2006) 1.52
Utility of mycobacterial interspersed repetitive unit typing for differentiating multidrug-resistant Mycobacterium tuberculosis isolates of the Beijing family. J Clin Microbiol (2005) 1.44
Lethal interaction: the colliding epidemics of tobacco and tuberculosis. Expert Rev Anti Infect Ther (2007) 1.41
Quinolone resistance determinant qnrA3 in clinical isolates of Salmonella in 2000-2005 in Hong Kong. J Antimicrob Chemother (2006) 1.40
Optimization of variable number tandem repeat typing set for differentiating Mycobacterium tuberculosis strains in the Beijing family. FEMS Microbiol Lett (2006) 1.37
Seasonal pattern of tuberculosis in Hong Kong. Int J Epidemiol (2005) 1.35
Tuberculosis in the global aging population. Infect Dis Clin North Am (2010) 1.34
Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility. Microb Drug Resist (2006) 1.32
EDTA susceptibility leading to false detection of metallo-beta-lactamase in Pseudomonas aeruginosa by Etest and an imipenem-EDTA disk method. Int J Antimicrob Agents (2005) 1.22
Roles of laboratories and laboratory systems in effective tuberculosis programmes. Bull World Health Organ (2007) 1.19
Characterization of a Bacillus anthracis isolate causing a rare case of fatal anthrax in a 2-year-old boy from Hong Kong. J Clin Microbiol (2005) 1.16
Treatment of tuberculosis and optimal dosing schedules. Thorax (2010) 1.13
Management of multidrug-resistant tuberculosis: Update 2007. Respirology (2008) 1.01
Exposure to avian influenza H7N9 in farms and wet markets. Lancet (2013) 1.00
Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol (2013) 0.98
Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing. PLoS One (2013) 0.98
Rapid pulsed-field gel electrophoresis protocol for subtyping of Streptococcus suis serotype 2. J Microbiol Methods (2006) 0.96
Household contact investigation of tuberculosis in low-income and middle-income countries: public-health impact. Lancet Infect Dis (2009) 0.96
Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. Thorax (2010) 0.95
Reexamining the role of radiography in tuberculosis case finding. Int J Tuberc Lung Dis (2011) 0.94
Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments. Biochem Biophys Res Commun (2004) 0.93
Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol (2013) 0.93
Streptococcus suis in retail markets: how prevalent is it in raw pork? Int J Food Microbiol (2008) 0.92
The association between symptoms and microbiologically defined response to tuberculosis treatment. Ann Am Thorac Soc (2013) 0.92
Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis. Clin Chim Acta (2009) 0.90
Quinolone resistance and correlation to other antimicrobial resistances in faecal isolates of Escherichia coli in Hong Kong. Chemotherapy (2008) 0.90
Association of polymorphisms in the Chr18q11.2 locus with tuberculosis in Chinese population. Hum Genet (2013) 0.90
Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis (2013) 0.90
Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells. PLoS One (2011) 0.90
Prognostic significance of early weight gain in underweight patients with tuberculosis. Am J Respir Crit Care Med (2006) 0.89
Emergence of CTX-M-type beta-lactam resistance in Shigella spp. in Hong Kong. Int J Antimicrob Agents (2005) 0.88
Initial experience on rifampin and pyrazinamide vs isoniazid in the treatment of latent tuberculosis infection among patients with silicosis in Hong Kong. Chest (2003) 0.88
Further evidence for a link between silica dust and esophageal cancer. Int J Cancer (2005) 0.88
Resistance to tetracycline, erythromycin and clindamycin in Streptococcus suis serotype 2 in Hong Kong. Int J Antimicrob Agents (2009) 0.87
Establishing CD4 thresholds for highly active antiretroviral therapy initiation in a cohort of HIV-infected adult Chinese in Hong Kong. AIDS Patient Care STDS (2007) 0.86
Standardization and international multicenter validation of a PulseNet pulsed-field gel electrophoresis protocol for subtyping Shigella flexneri isolates. Foodborne Pathog Dis (2012) 0.85
Routine use of a simple low-cost genotypic assay for the identification of mycobacteria in a high throughput laboratory. Diagn Microbiol Infect Dis (2003) 0.85
Update in tuberculosis 2008. Am J Respir Crit Care Med (2009) 0.84
A strong tuberculin reaction in primary school children predicts tuberculosis in adolescence. Pediatr Infect Dis J (2012) 0.83
Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons. Respirology (2013) 0.83
Update in tuberculosis 2007. Am J Respir Crit Care Med (2008) 0.82
Identification and characterization of tropomyosin 3 associated with granulin-epithelin precursor in human hepatocellular carcinoma. PLoS One (2012) 0.82
Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Genomics Proteomics Bioinformatics (2003) 0.81
Cost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in China. PLoS One (2013) 0.81
Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city. Eur Respir J (2012) 0.81
Update in tuberculosis 2005. Am J Respir Crit Care Med (2006) 0.80
Comparative genomic analysis of clinical and environmental strains provides insight into the pathogenicity and evolution of Vibrio parahaemolyticus. BMC Genomics (2014) 0.79
Does metabolic syndrome cause obstructive sleep apnoea? Respir Med (2007) 0.79
Solid-phase extraction clean-up of ciguatoxin-contaminated coral fish extracts for use in the mouse bioassay. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2009) 0.79
Year in review 2014: Lung cancer, pleural diseases, respiratory infections and tuberculosis, bronchoscopic intervention and imaging. Respirology (2015) 0.78
Corticosteroid administration and treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA (2010) 0.78
Diagnosing tuberculosis in patients with HIV: do we know enough? Am J Respir Crit Care Med (2009) 0.78
Acetaminophen and asthma: spurious association? Am J Respir Crit Care Med (2011) 0.78
Treatment of tuberculosis in HIV-infected patients: we need to know more. Am J Respir Crit Care Med (2007) 0.77
Harnessing the full sterilising activity of rifamycins. Int J Tuberc Lung Dis (2011) 0.77
The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate. Clin Infect Dis (2010) 0.77
Nutrient supplementation and tuberculosis treatment outcome. J Infect Dis (2009) 0.77
Draft genome sequence of Salmonella enterica serovar Typhimurium ST1660/06, a multidrug-resistant clinical strain isolated from a diarrheic patient. J Bacteriol (2012) 0.77
Trends in multidrug-resistant Mycobacterium tuberculosis in relation to sputum smear positivity in Hong Kong, 1989-1999. Clin Infect Dis (2001) 0.77
T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts. Respirology (2015) 0.77
Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection. Int J Tuberc Lung Dis (2006) 0.76
Smoking and tuberculosis: infection, disease, and mortality. Arch Intern Med (2007) 0.76
Update in tuberculosis 2006. Am J Respir Crit Care Med (2007) 0.76
Development of an ICR mouse bioassay for toxicity evaluation in neurotoxic poisoning toxins-contaminated shellfish. Biomed Environ Sci (2013) 0.76
Year in review 2011: respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging. Respirology (2012) 0.75
Inhaled corticosteroids might not protect against lung cancer. Am J Respir Crit Care Med (2008) 0.75
Moxifloxacin versus ethambutol in initial tuberculosis treatment. Lancet (2009) 0.75
How should we treat "difficult" multidrug-resistant tuberculosis? Chest (2009) 0.75
A cost-effective and universal strategy for complete prokaryotic genomic sequencing proposed by computer simulation. BMC Res Notes (2012) 0.75
Side effects of antituberculosis therapy. Am J Respir Crit Care Med (2004) 0.75
Acquired rifamycin mono-resistance and dosing schedules in HIV-related tuberculosis. Am J Respir Crit Care Med (2010) 0.75
Streptomycin susceptibility and MDR-TB: can we refine the definition of XDR-TB? Am J Respir Crit Care Med (2011) 0.75
Does current drug resistance surveillance provide useful information in tuberculosis? Am J Respir Crit Care Med (2009) 0.75
Lung cancer is more common in early GOLD stages of COPD: a spurious association? Am J Respir Crit Care Med (2012) 0.75
Can the interferon-gamma release assay help diagnose active tuberculosis in the elderly? Chest (2008) 0.75
Toward optimizing treatment for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2007) 0.75
Can some patients with multidrug-resistant tuberculosis be cured with shorter duration of chemotherapy? Am J Respir Crit Care Med (2010) 0.75